Schwartz Investment Counsel’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.8M Sell
372,500
-2,000
-0.5% -$149K 0.92% 42
2025
Q1
$23.8M Buy
374,500
+223,500
+148% +$14.2M 0.82% 40
2024
Q4
$11.8M Hold
151,000
0.42% 63
2024
Q3
$12.1M Hold
151,000
0.43% 65
2024
Q2
$12.5M Hold
151,000
0.46% 62
2024
Q1
$12.9M Buy
151,000
+32,000
+27% +$2.73M 0.47% 57
2023
Q4
$10.2M Hold
119,000
0.4% 68
2023
Q3
$10.7M Sell
119,000
-40,000
-25% -$3.58M 0.46% 64
2023
Q2
$13.5M Hold
159,000
0.57% 50
2023
Q1
$13.2M Sell
159,000
-25,000
-14% -$2.07M 0.58% 50
2022
Q4
$14.5M Hold
184,000
0.66% 47
2022
Q3
$13.6M Sell
184,000
-5,000
-3% -$370K 0.7% 44
2022
Q2
$12.3M Hold
189,000
0.6% 47
2022
Q1
$11.9M Buy
189,000
+51,000
+37% +$3.22M 0.5% 51
2021
Q4
$7.32M Buy
138,000
+28,000
+25% +$1.49M 0.28% 62
2021
Q3
$7.77M Buy
110,000
+20,000
+22% +$1.41M 0.32% 58
2021
Q2
$6M Buy
90,000
+30,000
+50% +$2M 0.24% 69
2021
Q1
$6.66M Hold
60,000
0.29% 59
2020
Q4
$7.13M Buy
60,000
+10,000
+20% +$1.19M 0.32% 58
2020
Q3
$4.36M Buy
50,000
+25,000
+100% +$2.18M 0.22% 66
2020
Q2
$2.24M Buy
+25,000
New +$2.24M 0.12% 77